IDH1 and central nervous system cancer: In molecular groups of gliomas that have gained the telomerase reverse transcriptase (TERT) promoter mutation, IDH mutation, and 1p/19q codeletion, rs6010620 serves as protection against glioma susceptibility in TERT mutation status [14].